These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37922950)

  • 21. Clinicopathologic study of endometrial dedifferentiated endometrioid adenocarcinoma: a case report.
    Shen Y; Wang Y; Shi Y; Liu J; Liu Y
    Int J Clin Exp Pathol; 2012; 5(1):77-82. PubMed ID: 22295150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report.
    Valtcheva N; Lang FM; Noske A; Samartzis EP; Schmidt AM; Bellini E; Fink D; Moch H; Rechsteiner M; Dedes KJ; Wild PJ
    BMC Cancer; 2017 Jan; 17(1):66. PubMed ID: 28103826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of tumor suppressor gene product p14ARF in endometrioid adenocarcinoma of the uterine corpus.
    Watanabe J; Nishizaki R; Jobo T; Kamata Y; Hata H; Nishimura Y; Fujisawa T; Okayasu I; Kuramoto H
    Int J Gynecol Pathol; 2004 Jul; 23(3):234-40. PubMed ID: 15213599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Targeted Next-Generation Sequencing Shows Increased Mutational Load in Endometrioid-type Endometrial Adenocarcinoma With Deficient DNA Mismatch Repair.
    Lee PJ; McNulty S; Duncavage EJ; Heusel JW; Hagemann IS
    Int J Gynecol Pathol; 2018 Nov; 37(6):581-589. PubMed ID: 29084048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.
    Yano M; Shintani D; Katoh T; Hamada M; Ito K; Kozawa E; Hasegawa K; Yasuda M
    Diagn Pathol; 2019 Jun; 14(1):54. PubMed ID: 31174566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic features of endometrioid-type endometrial carcinoma arising in uterine adenomyosis.
    Yoshida H; Asami Y; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Shiraishi K; Kato T
    Virchows Arch; 2022 Jul; 481(1):117-123. PubMed ID: 34791535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
    Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular evidence for a clonal relationship between synchronous uterine endometrioid carcinoma and ovarian clear cell carcinoma: a new example of "precursor escape"?
    Weng CH; Wu RC; Chen SJ; Chen HC; Tan KT; Lee YS; Huang SS; Yang LY; Wang CJ; Chou HH; Chao AS; Chao A; Lai CH
    J Mol Med (Berl); 2021 Jul; 99(7):959-966. PubMed ID: 33768299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
    Kashima H; Wu RC; Wang Y; Sinno AK; Miyamoto T; Shiozawa T; Wang TL; Fader AN; Shih IeM
    Gynecol Oncol; 2015 Nov; 139(2):338-44. PubMed ID: 26343160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological and molecular characteristics of endometrial neuroendocrine carcinomas reveal preexisting endometrial carcinoma origin.
    Ono K; Kasajima R; Katayama K; Miyagi Y; Yokose T
    Pathol Int; 2021 Aug; 71(8):491-499. PubMed ID: 34015161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
    An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
    Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profiling of endometrial adenocarcinomas reveals increased apolipoprotein E expression in poorly differentiated tumors.
    Huvila J; Brandt A; Rojas CR; Pasanen S; Talve L; Hirsimäki P; Fey V; Kytömäki L; Saukko P; Carpén O; Soini JT; Grénman S; Auranen A
    Int J Gynecol Cancer; 2009 Oct; 19(7):1226-31. PubMed ID: 19823059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synchronous clear cell adenocarcinoma of the cervix and endometrioid carcinoma of the endometrium.
    Park ST; Song MJ; Lee CW; Lee AW; Hur SY; Park JS
    Eur J Gynaecol Oncol; 2011; 32(5):573-5. PubMed ID: 22053679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.
    Huang HN; Lin MC; Tseng LH; Chiang YC; Lin LI; Lin YF; Huang HY; Kuo KT
    Histopathology; 2015 Mar; 66(4):517-28. PubMed ID: 25195947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J
    Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corded and Hyalinized Endometrioid Adenocarcinoma (CHEC) of the Uterine Corpus are Characterized by CTNNB1 Mutations and Can Show Adverse Clinical Outcomes.
    Ladwig NR; Umetsu SE; Zaloudek C; Rabban J; Garg K
    Int J Gynecol Pathol; 2021 Mar; 40(2):103-115. PubMed ID: 32909971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of hysteroscopic imaging in endometrioid endometrial adenocarcinoma.
    Garuti G; De Giorgi O; Sambruni I; Cellani F; Luerti M
    Gynecol Oncol; 2001 Jun; 81(3):408-13. PubMed ID: 11371130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial Endometrioid Carcinoma With Large Cystic Growth Configuration and Deceptive Pattern of Invasion Associated With Abundant Nodular Fasciitis-like Stroma: A Unique Hitherto Unreported Histology in Endometrioid Carcinoma.
    Švajdler M; Michal M; Dubinský P; Švajdler P; Ondič O; Michal M
    Adv Anat Pathol; 2016 Nov; 23(6):381-384. PubMed ID: 27740962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyr61, a member of ccn (connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed) family, predicts survival of patients with endometrial cancer of endometrioid subtype.
    Watari H; Xiong Y; Hassan MK; Sakuragi N
    Gynecol Oncol; 2009 Jan; 112(1):229-34. PubMed ID: 19007976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
    El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
    Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.